US Treasury Secretary Scott Bessent announced a surprise increase in liquidity-support buybacks in the 10- to 30-year sector, doubling the size from 9 September after the 30-year yield moved above 5.30% and the 10-year rose further. Markets reacted quickly: the 30-year yield fell about 10 bps to 5.18% and the 10-year eased towards 4.65%, while the dollar hit a three-month low. Gold jumped $190, up 4.35%, breaking above $4,500, and stock futures swung from negative to positive. The move was framed as duration being removed from the market, potentially funded by greater short-term T-bill issuance, with the note that it does not change the near-$40trn national debt or refinancing needs; by the next session the rally had begun to fade, with the 10-year at 4.67% (+2 bps) and the 30-year at 5.22% (+3 bps).
Energy prices stayed firm, with Brent up $2 to $93.60 and WTI up $2 to $87.80, adding to inflation concerns as US equities ended higher after three down days. The Dow rose 120 points, the S&P 500 gained 16 to close at 7,707 and the Nasdaq added 41, while the Russell increased 15 and Transports fell 35; the equal-weight S&P rose 92 and the Mag 7 added 424. Fed minutes showed three policymakers favoured a 25 bps rise in July and ‘several’ leaned towards further tightening. In earnings, Target posted comparable sales of 3.8%, traffic growth of 3.6% and digital sales up nearly 9%, while Walmart is expected to report $0.74 a share on $187bn of revenue; Lowe’s beat earnings but missed revenue and cut its sales outlook, and TJX raised its profit forecast. Merck and Moderna said their intismeran plus Keytruda met endpoints in a Phase 3 melanoma study of more than 1,100 patients; Moderna shares surged 176% ($111) and Merck gained roughly 10%. European bourses were lower, with Germany down 0.5% and Spain off 0.1%, while US futures showed the Dow down 90, the S&P down 2, the Nasdaq up 26 and the Russell down 3; support was cited at 7,700, with trendline support at 7,500 and resistance at 7,900–8,000, while Nvidia expectations centred on $92–94bn of revenue and options implied a 7% or about $15 move within a $195/$240 range.
Bond Market Volatility and Tactical Positioning
We just saw the Treasury step in with a surprise doubling of its liquidity-support buybacks starting September 9, temporarily cooling the 10-year yield to 4.65% and sending gold screaming past $4,500. While this artificial demand sparked a brief relief rally in stocks, the underlying reality of our $40 trillion national debt and massive deficit remains completely unchanged. Derivative traders must recognize that this intervention is a temporary band-aid, which is why we should prepare for yields to resume their upward march.
The bond market is already testing this intervention, with the 10-year yield creeping back up to 4.67% and Brent crude pushing past $93 a barrel to threaten fresh inflation. With the latest Fed minutes revealing a hawkish undercurrent where several policymakers still want to push short-term rates higher, the macro backdrop remains highly volatile. We recommend using interest rate swaps or buying put options on long-duration Treasury ETFs like TLT to position for the next leg up in yields.
Equity Strategies and Sector Rotation
Historically, September is the absolute worst month of the year for equities, with the S&P 500 averaging a 1.2% decline since 1928. With the index currently sitting near 7,707, we expect a retest of the 7,700 level, which could quickly open the door to major trendline support at 7,500 if the bond market rout continues. To protect our portfolios against this looming seasonal drawdown, we should look at buying near-term protective puts on the S&P 500 or utilizing bear put spreads to limit downside risk.
Next week’s Nvidia earnings will be the ultimate volatility catalyst, with the options market currently pricing in a massive 7% price swing in either direction. Because the stock is locked in a tight $195 to $240 trading range, the implied volatility is incredibly high. We should consider using long straddles to capture a breakout beyond these levels, or credit spreads to capture the premium crush once the news is digested.
Meanwhile, the explosive 176% surge in Moderna and 10% jump in Merck show that money is rapidly rotating into defensive sectors and high-conviction headlines. This rotation out of crowded tech trades means we need to pivot our equity options strategy away from growth and toward defensive value. We suggest executing bull call spreads on healthcare and consumer staples, which will likely act as safe havens as we navigate a turbulent September.
